Method for producing histidine zinc dihydrate

The described method addresses the issue of impurity formation in zinc histidine dihydrate production by filtering and crystallizing under controlled conditions, resulting in a highly pure and stable pharmaceutical-grade product.

JP2024164859APending Publication Date: 2024-11-28NOBELPHARMA CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023080522
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-16
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing methods for producing zinc histidine dihydrate fail to achieve high purity, leading to the production of impurities and unsuitable crystal forms.

Method used

A method involving the dissolution of L-histidine in water with zinc oxide, followed by filtration to remove unreacted zinc oxide and foreign substances, crystallization at controlled temperatures, and careful drying under reduced pressure to obtain highly purified zinc histidine dihydrate.

Benefits of technology

The method produces highly purified zinc histidine dihydrate suitable for pharmaceutical use, ensuring high purity and stability of the crystal form.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024164859000003
    Figure 2024164859000003
  • Figure 2024164859000004
    Figure 2024164859000004
  • Figure 2024164859000005
    Figure 2024164859000005
Patent Text Reader

Abstract

To provide high-purity histidine zinc dihydrate, which is useful as a pharmaceutical.SOLUTION: There is provided a method for producing histidine zinc dihydrate including following steps 1 to 4: Step 1: a step of adding L-histidine in water and dissolving L-histidine in water, then adding zinc oxide to the L-histidine solution, and reacting the mixture while stirring and heating the mixture; Step 2: a step of filtering the reaction liquid with a filter to remove unreacted zinc oxide and foreign matters; Step 3: a step of crystallizing the obtained filtrate at a temperature of 4°C to 30°C, and separating the obtained solid; and Step 4: a step of heating the separated solid to dry it.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing zinc histidine dihydrate (JAN), specifically, to a method for producing high-purity zinc histidine dihydrate useful as a medicine (e.g., a medicine for treating Wilson's disease, hypozincemia, etc.). [Background technology]

[0002] Methods for preparing zinc histidine are known. For example, Chinese Patent Publication No. 113185464 describes the following preparation method for zinc histidine.

[0003] Here, L-histidine and a zinc source (zinc oxide or zinc hydroxide) are mixed with water, a chelation reaction is carried out to obtain a chelated product system, the chelated product system is concentrated, and then cooled and crystallized to obtain zinc histidine. Here, zinc oxide or zinc hydroxide is used as the zinc source, no alkaline reagent is required to adjust the pH value of the reaction system, L-histidine, a zinc source and water are directly mixed, and zinc histidine is produced in a one-step manner. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] China Patent Publication No. 113185464 Summary of the Invention [Problem to be solved by the invention]

[0005] In examining a method for producing zinc histidine dihydrate, the present inventors have studied the contents of Patent Document 1 and have found that the method described in Patent Document 1 does not produce high-purity zinc histidine dihydrate, as described below.

[0006] That is, an object of the present invention is to provide a method for producing high-purity zinc histidine dihydrate. [Means for solving the problem]

[0007] That is, the present invention provides the following [1] to [5]: [1] A method for producing zinc histidine dihydrate, comprising the following steps 1 to 4: Step 1: adding and dissolving L-histidine in water, then adding zinc oxide and reacting with stirring and heating; Step 2: filtering the reaction solution through a filter to remove unreacted zinc oxide and foreign matter; Step 3: crystallizing the obtained filtrate at a temperature of 4° C. to 30° C. and separating the obtained solid matter; and Step 4: The separated solid matter is heated and dried. [2] The method according to [1], wherein in step 1, the amount of L-histidine added is at least twice as much as the amount of zinc oxide added by molar ratio. [3] The method according to [1] or [2], wherein in step 4, the heating temperature is 20°C or higher and lower than 40°C, and the drying time is 4 hours to 120 hours. [4] The method according to [1] or [2], wherein in step 1, the reaction is carried out at a temperature of 70°C to 85°C. [5] The method according to [4], in step 1, the reaction is carried out for 30 to 90 minutes. Effect of the Invention

[0008] According to the present invention, it is possible to provide a method for producing high-purity zinc histidine dihydrate. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] The method of the present invention will now be described in detail.

[0010] The method of the present invention is a method for producing zinc histidine dihydrate, and includes the following steps 1 to 4: Step 1: adding and dissolving L-histidine in water, then adding zinc oxide and reacting with stirring and heating; Step 2: filtering the reaction solution through a filter to remove unreacted zinc oxide and foreign matter; Step 3: crystallizing the obtained filtrate at a temperature of 4° C. to 30° C. and separating the obtained solid matter; and Step 4: The separated solid matter is heated and dried.

[0011] Process 1 L-histidine is added to water and dissolved, and zinc oxide is added thereto. The amount of zinc oxide to be added is set so that the amount of L-histidine is at least twice as much as the amount of zinc oxide to be added in terms of molar ratio. The amount ratio of L-histidine to zinc oxide in step 1 does not need to be particularly limited as long as the amount of L-histidine is at least twice as much as the amount of zinc oxide in terms of molar ratio, but the molar ratio of L-histidine:zinc oxide is preferably 2.0 to 2.5:1, and more preferably 2.0 to 2.1:1. If the amount of L-histidine relative to zinc oxide is small, the reaction does not proceed sufficiently, and unreacted zinc oxide remains, which is not preferable. In step 1, this reaction solution is heated while being stirred to allow the reaction to proceed sufficiently.

[0012] The heating temperature is 60 to 85° C., preferably 70 to 85° C., more preferably 70 to 78° C., and further preferably 74° C. If the temperature is less than 60° C., the reaction rate decreases, and if the temperature exceeds 85° C., there is a risk of coloration in the subsequent steps.

[0013] The reaction time is 10 to 120 minutes, preferably 30 to 90 minutes, for example, 60 minutes.

[0014] The amount of water used is not limited as long as it is an amount sufficient to dissolve L-histidine, and may be, for example, an amount that dissolves zinc histidine produced at the reaction temperature.

[0015] In step 1, the molar ratio of zinc oxide to L-histidine used is close to the theoretical amount, so it is believed that there is almost no unreacted zinc oxide. Even if a small amount of unreacted zinc oxide remains, it is removed by filtration in step 2.

[0016] Process 2 The reaction liquid obtained in step 1 is filtered through a filter to remove unreacted zinc oxide and foreign matter.

[0017] The pore size of the filter used for filtration is 0.1 to 3 μm.

[0018] In one embodiment, the filter used for filtration may be a stack of multiple filters, for example, filters with pore sizes of 1 μm and 0.2 μm, such as cartridge filters, may be stacked.

[0019] Process 3 The filtrate obtained in step 2 is crystallized at a temperature at which the reaction liquid does not freeze and the target zinc histidine precipitates, and the resulting solid crystals are separated.

[0020] The crystallization temperature is not limited as long as it is a temperature at which zinc histidine precipitates, and may be, for example, 4°C to 30°C.

[0021] In one embodiment, the crystallization temperature is 35° C. or less, preferably 4° C. to 20° C. In particular, a high yield can be obtained by crystallization at a temperature of about 4 to 7° C. On the other hand, if the temperature exceeds 30° C., a decrease in the yield is observed.

[0022] In another embodiment, the crystallization temperature is from 1°C to 20°C.

[0023] The crystallization time is, for example, 1 to 48 hours, and preferably 12 to 24 hours.

[0024] The crystals can be separated, for example, by centrifugation.

[0025] In one embodiment, in step 3, the filtrate obtained in step 2 is crystallized under cooling at 10° C. or less for 12 hours or more. When the concentration of zinc histidine dihydrate in the mother liquor from which the crystals are crystallized becomes 3% or less, the crystallization is terminated. Then, the liquid is centrifuged to separate the crystals.

[0026] Process 4 The crystals separated in step 3 are heated and dried. The drying time is, for example, 4 to 120 hours, preferably 8 to 100 hours, and particularly preferably 10 to 24 hours.

[0027] The drying temperature is, for example, from 20°C to less than 40°C, preferably from 20°C to 35°C, more preferably from 22°C to 35°C, and particularly preferably from 23°C to 30°C.

[0028] The drying may be carried out under reduced pressure. The reduced pressure conditions may be, for example, a vacuum degree of 6 to 14 hPa, and preferably 10 to 14 hPa.

[0029] In one embodiment, in step 4, drying is performed at a degree of vacuum of 10 to 14 hPa, preferably 12 hPa, and at a temperature of 20 to less than 40° C., for example, at 23° C., for 10 hours or longer.

[0030] The thus obtained zinc histidine dihydrate has high purity and can be used as a pharmaceutical raw material. EXAMPLES

[0031] The present invention will be described below with reference to specific embodiments, but it will be understood that the present invention is not limited to these embodiments, and that various changes and modifications therein can be made by those skilled in the art without departing from the scope or spirit of the present invention as defined in the appended claims.

[0032] Example 1 Preparation of zinc histidine dihydrate Step 1: Reaction 906 kg of purified water was charged into a reactor and heated to 78°C, then 75.7 kg of L-histidine was charged and while maintaining the temperature at 78°C, 19.9 kg of zinc oxide was added and reacted for 60 minutes with stirring. The reaction liquid was initially in a suspended state due to the zinc oxide, but when the reaction was completed, it changed to an almost transparent liquid.

[0033] Step 2: Filtration / crystallization The reaction solution obtained in step 1 was transferred to a crystallizer while being filtered through two cartridge filters with pore sizes of 1 μm and 0.2 μm. The crystallizer was then cooled and maintained at 7°C for 12 hours or more for cooling and crystallization. The suspension from which the crystals had crystallized was sampled, and crystallization was terminated when the concentration of zinc histidine dihydrate in the supernatant liquid became 3% or less.

[0034] Step 3: Centrifugal filtration and drying After centrifugal filtration of the suspension from which the crystals had crystallized in step 2, half of the obtained wet crystals were placed in two dryers and dried under reduced pressure at 10 hPa while maintaining the room in which the dryers were installed at approximately 22°C. Drying was terminated when the temperature of the crystals reached 20°C or higher and more than 12 hours had passed. The same procedure was repeated for the remaining half of the wet crystals. The moisture content of the dried product is shown in Table 1.

[0035] The obtained zinc histidine dihydrate was subjected to TG-DTA measurement. The obtained chart is shown in Figure 1. Similarly, the obtained zinc histidine dihydrate was subjected to DSC measurement. The obtained chart is shown in Figure 2.

[0036] Furthermore, the infrared absorption spectrum of the obtained zinc histidine dihydrate is shown in FIG. 3, the X-ray diffraction pattern (XRD) is shown in FIG. 1 The H-NMR spectrum is shown in Figure 5. 13 The C-NMR spectra are shown in FIG.

[0037] Example 2 Dryer temperature and vacuum conditions in the drying process Using a temperature-controllable dryer, the temperature was set to 20°C, 30°C, 35°C, and 40°C, and the vacuum was set to 6hPa, 7hPa, 10hPa, 12hPa, and 14hPa, and the same production as in Example 1 was carried out. The moisture content of the dried product is shown in Table 1.

[0038] [Table 1]

[0039] Comparative Example 1: Production of zinc histidine in Patent Document 1 (Example 1 in Patent Document 1) L-histidine and zinc oxide were mixed homogeneously in a molar ratio of 2.5:1, dissolved in water, stirred, and reacted in a constant temperature water bath at 50°C for 2 hours under the condition of 300 rpm. The resulting product system was filtered, and the filtrate was concentrated using a rotary evaporator. After the resulting concentrated solution was cooled to room temperature (25°C), the mouth of the beaker filled with the concentrated solution was covered with plastic wrap, a small hole was made in the wrap to promote evaporation of the solvent, and the beaker was frozen at -4°C for 12 hours. After the crystals precipitated, the resulting crystals were dried in a vacuum dryer at 60°C for 4 hours to obtain zinc histidine (nitrogen content: 20.24%).

[0040] The physical properties of zinc histidine dihydrate obtained by the method of the present invention were compared with those of zinc histidine described in Patent Document 1 (Table 2).

[0041] [Table 2]

[0042] The TG-DTA chart of zinc histidine in Patent Document 1 is shown in FIG. 7, the infrared absorption spectrum in FIG. 8, and the X-ray diffraction pattern in FIG.

[0043] From the above data, it is presumed that the method of Patent Document 1 does not produce dihydrate with sufficient purity, and that tetrahydrate is mainly produced because the data of crystal form (space group) is shown as tetragonal (P43212). In the method of Patent Document 1, dehydration occurs at 60°C, but it is considered that dehydration is not achieved because of the short time, and drying is insufficient. In other words, the drying conditions of Patent Document 1 are insufficient in a short time, and dehydration occurs in a long time, and it is considered that they are not suitable for stable production of histidine zinc dihydrate or production of histidine zinc dihydrate of pharmaceutical quality. [Industrial Applicability]

[0044] According to the present invention, highly pure zinc histidine dihydrate, which is useful as a medicine, can be produced simply and reliably. [Brief description of the drawings]

[0045] [Figure 1] 1 is a TG-DTA chart of zinc histidine dihydrate obtained by the method of the present invention. [Diagram 2] 1 is a DSC chart of zinc histidine dihydrate obtained by the method of the present invention. [Diagram 3] 1 is an infrared absorption spectrum of zinc histidine dihydrate obtained by the method of the present invention. [Figure 4] 1 is an X-ray diffraction pattern of zinc histidine dihydrate obtained by the method of the present invention. [Figure 5A] 1 shows the 1H-NMR spectrum assignments of zinc histidine dihydrate obtained by the method of the present invention. [Figure 5B] 1 is a 1H-NMR spectrum of zinc histidine dihydrate obtained by the method of the present invention. [Figure 5C] 1 is a 1H-NMR spectrum of zinc histidine dihydrate obtained by the method of the present invention (around 2.7-4.5 ppm). [Figure 5D] 1 is a 1H-NMR spectrum of zinc histidine dihydrate obtained by the method of the present invention (around 6.7-8.4 ppm). [Figure 6]1 is a 13C-NMR spectrum of zinc histidine dihydrate obtained by the method of the present invention. [Figure 7] 1 is a TG-DTA chart of zinc histidine described in Patent Document 1. [Figure 8] This is an infrared absorption spectrum of zinc histidine described in Patent Document 1. The upper line in the graph is histidine, and the lower line is zinc histidine. [Figure 9] 1 is an X-ray diffraction pattern of zinc histidine described in Patent Document 1.

Claims

1. A method for producing zinc histidine dihydrate, comprising the following steps 1 to 4: Step 1: adding and dissolving L-histidine in water, then adding zinc oxide and reacting with stirring and heating; Step 2: filtering the reaction solution to remove unreacted zinc oxide and foreign matter; Step 3: crystallizing the obtained filtrate at a temperature between 4° C. and 30° C. and separating the obtained solid; and Step 4: Heating and drying the separated solid matter.

2. 2. The method according to claim 1, wherein in step 1, the molar ratio of L-histidine to zinc oxide is at least twice as much.

3. The method according to claim 1 or 2, wherein in step 4, the heating temperature is 20° C. to 35° C., and the drying time is 4 hours to 120 hours.

4. The method according to claim 1 or 2, wherein in step 1, the reaction is carried out at a temperature of 70°C to 85°C.

5. The method according to claim 4, wherein the reaction in step 1 is carried out for 30 to 90 minutes.

Citation Information

Patent Citations

  • Preparation method of zinc histidine

    CN113185464A